Skip to main content
Top
Published in: The Journal of Obstetrics and Gynecology of India 4/2015

01-07-2015 | Original Article

Comparative Study of Misoprostol in First and Second Trimester Abortions by Oral, Sublingual, and Vaginal Routes

Authors: Deepika Nautiyal, Krishna Mukherjee, Inderjeet Perhar, Navnita Banerjee

Published in: The Journal of Obstetrics and Gynecology of India | Issue 4/2015

Login to get access

Abstract

Objective

To identify an effective misoprostol-only regimen for termination of pregnancy between 12 and 20 weeks of gestation, a prospective randomized study comparing sublingual, vaginal, and oral routes of administration of misoprostol was done.

Methods

One hundred and fifty women (12–20 weeks gestation) were randomly divided into three groups and given 400 mcg misoprostol sublingually, vaginally, and orally every 4 h up to a maximum of four doses. Primary outcome was the success rate at 24 h. Secondary outcomes were failure rate, induction–abortion interval, and need for surgical intervention. Various side effects and patients’ subjective assessment of comfort with the route of administration were also studied.

Results

Success rate at 24 h of sublingual (86 %) group was higher compared to oral (64 %) group (P = 0.011). Complete abortion rate of sublingual (76 %) group was higher than that of oral (48 %) group (P = 0.004). There was no significant difference in the failure rate and need for surgical intervention in the three groups. Induction–abortion interval in sublingual (9.8 ± 3.6 h) and vaginal (10.6 ± 2.9 h) groups was shorter than that in oral group (14.3 ± 3.3). Diarrhea occurred significantly more in the oral group (28 %) and sublingual (22 %) compared to vaginal group (6 %). Fever was significantly higher in vaginal (36 %) than that in the oral group (12 %). Oral route of administration was most comfortable.

Conclusion

Sublingual route results in significantly higher abortion rate compared to oral route. Vaginal route has efficacy similar to sublingual route.
Literature
1.
go back to reference Borgatta L, Kapp N. Labor induction abortion in the second trimester. Contraception. 2011;84(1):4–18.PubMedCrossRef Borgatta L, Kapp N. Labor induction abortion in the second trimester. Contraception. 2011;84(1):4–18.PubMedCrossRef
2.
go back to reference Ashok PW, Flett GM, Templeton A. Termination of pregnancy at 9–13 weeks amenorrhoea with mifepristone and misoprostol. Lancet. 1998;352:542–3.PubMedCrossRef Ashok PW, Flett GM, Templeton A. Termination of pregnancy at 9–13 weeks amenorrhoea with mifepristone and misoprostol. Lancet. 1998;352:542–3.PubMedCrossRef
3.
go back to reference Singh K, Fong YF, Prasad RNV, et al. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre abortion cervical priming? Hum Reprod. 1999;14:1635–7.PubMedCrossRef Singh K, Fong YF, Prasad RNV, et al. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre abortion cervical priming? Hum Reprod. 1999;14:1635–7.PubMedCrossRef
4.
go back to reference Tang OS, Schweer H, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod. 2002;17:332–6.PubMedCrossRef Tang OS, Schweer H, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod. 2002;17:332–6.PubMedCrossRef
5.
go back to reference Tang OS, Miao BY, Lee SWH, et al. Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks of gestation: efficacy and acceptability. Hum Reprod. 2002;17:654–8.PubMedCrossRef Tang OS, Miao BY, Lee SWH, et al. Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks of gestation: efficacy and acceptability. Hum Reprod. 2002;17:654–8.PubMedCrossRef
6.
go back to reference Tang OS, Xu J, Cheng L, et al. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks of gestation. Hum Reprod. 2002;17:1734–48. Tang OS, Xu J, Cheng L, et al. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks of gestation. Hum Reprod. 2002;17:1734–48.
7.
go back to reference Tang OS, Ho PC. Pilot study on the use of sublingual misoprostol on medical abortion. Contraception. 2001;64:315–7.PubMedCrossRef Tang OS, Ho PC. Pilot study on the use of sublingual misoprostol on medical abortion. Contraception. 2001;64:315–7.PubMedCrossRef
8.
go back to reference Dickinson JE, Evans SF. The optimization of intra vaginal misoprostol dosing schedules in second trimester pregnancy termination. Am J Obstet Gynecol. 2002;186:470–4.PubMedCrossRef Dickinson JE, Evans SF. The optimization of intra vaginal misoprostol dosing schedules in second trimester pregnancy termination. Am J Obstet Gynecol. 2002;186:470–4.PubMedCrossRef
9.
go back to reference Ashok PW, Templeton A. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynecol. 1999;106:706–10.CrossRef Ashok PW, Templeton A. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynecol. 1999;106:706–10.CrossRef
10.
go back to reference Mahjabeen, Khawaja NP, Rehman R. Comparison of oral versus vaginal misoprostol for mid-trimester pregnancy termination. J Coll Phys Surg Pak. 2009;19(6):359–62. Mahjabeen, Khawaja NP, Rehman R. Comparison of oral versus vaginal misoprostol for mid-trimester pregnancy termination. J Coll Phys Surg Pak. 2009;19(6):359–62.
11.
go back to reference Karsidaq AY, Buyukbayrak EE, Kars B, et al. Vaginal versus sublingual misoprostol for second trimester pregnancy termination and effect on Doppler measurements. Int J Gynaecol Obstet. 2009;106(3):250–3.CrossRef Karsidaq AY, Buyukbayrak EE, Kars B, et al. Vaginal versus sublingual misoprostol for second trimester pregnancy termination and effect on Doppler measurements. Int J Gynaecol Obstet. 2009;106(3):250–3.CrossRef
12.
go back to reference Tanha FD, Golgachi T, Niroomand N, et al. Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial. Arch Gynecol Obstet. 2013;287(1):65–9.PubMedCrossRef Tanha FD, Golgachi T, Niroomand N, et al. Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial. Arch Gynecol Obstet. 2013;287(1):65–9.PubMedCrossRef
13.
go back to reference Tang OS, Lau WNT, Chan CCW, et al. A prospective randomized comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. BJOG: Int J Obst Gynaecol. 2004;111:1001–5.CrossRef Tang OS, Lau WNT, Chan CCW, et al. A prospective randomized comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. BJOG: Int J Obst Gynaecol. 2004;111:1001–5.CrossRef
14.
go back to reference Von Hertzen H, Piaggio G, Wojdyla D, et al. WHO Research Group on Post-ovulatory methods of Fertility Regulation. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial. Hum Reprod. 2009;24(1):10. Von Hertzen H, Piaggio G, Wojdyla D, et al. WHO Research Group on Post-ovulatory methods of Fertility Regulation. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial. Hum Reprod. 2009;24(1):10.
Metadata
Title
Comparative Study of Misoprostol in First and Second Trimester Abortions by Oral, Sublingual, and Vaginal Routes
Authors
Deepika Nautiyal
Krishna Mukherjee
Inderjeet Perhar
Navnita Banerjee
Publication date
01-07-2015
Publisher
Springer India
Published in
The Journal of Obstetrics and Gynecology of India / Issue 4/2015
Print ISSN: 0971-9202
Electronic ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-014-0587-3

Other articles of this Issue 4/2015

The Journal of Obstetrics and Gynecology of India 4/2015 Go to the issue

Instrumentation and Techniques

Customized Silicone Vaginal Stent